BCL3 and neoplasm: PD-L1 is known to inhibit tumour infiltrating lymphocytes (68); therefore, it is tempting to speculate that BCL-3 could play a similar role in protecting against tumour cell apoptosis via regulation of tumour infiltrating lymphocytes in both hepatocellular carcinoma and ovarian cancer.